Understanding Lineage Plasticity as a Path to Targeted Therapy Failure in EGFR-Mutant Non-small Cell Lung Cancer

Understanding Lineage Plasticity as a Path to Targeted Therapy Failure in EGFR-Mutant Non-small Cell Lung Cancer

Somatic alterations in the epidermal growth factor receptor gene (EGFR) result in aberrant activation of kinase signaling and occur in ∼15% of non-small cell lung cancers (NSCLC). Patients diagnosed with EGFR-mutant NSCLC have good initial clinical response to EGFR tyrosine kinase inhibitors (EGFR T...

Full description

Bibliographic Details
Main Authors: Tatiana Shaurova, Letian Zhang, David W. Goodrich, Pamela A. Hershberger
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-03-01
Series:Frontiers in Genetics
Subjects:
EGFR mutant lung cancer
EGFR tyrosine kinase inhibitors
acquired resistance
lineage plasticity
epithelial-mesenchymal transition
neuroendocrine transformation
Online Access:https://www.frontiersin.org/article/10.3389/fgene.2020.00281/full

Internet

https://www.frontiersin.org/article/10.3389/fgene.2020.00281/full

Similar Items